Skip to main content

Advertisement

Log in

Behavioral Therapy for Chronic Migraine

  • Chronic Daily Headache (SJ Wang, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Chronic migraine is a disabling condition which affects a considerable proportion of patients. Several risk factors and lifestyle habits contribute to the transformation of migraine into a chronic form. Behavioral treatments, including relaxation, biofeedback, and cognitive behavioral therapy reduce the risk of episodic into chronic migraine transformation, thus restraining the headache-related disability. The rationale of behavioral therapies is that a medical problem should be recognized and thoroughly examined by the patient to be successfully managed. Being aware of factors which precipitate or aggravate migraine allows patients to progressively modulate the frequency and duration of their attacks. Similarly, the acquisition of healthy habits improves the quality of life and the subjective well-being of patients and contributes to breaking the vicious cycle that leads to migraine chronification. The highest level of care is achieved when behavioral therapies are integrated with other treatments, including physical and pharmacological interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Seattle: IASP Press; 1994.

    Google Scholar 

  2. • Von Korff M, Dunn KM. Chronic pain reconsidered. Pain. 2008;138:267–76. This reference is of importance to understand the correct way to consider and diagnose chronic pain and to predict its clinic course.

    Article  Google Scholar 

  3. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache. 2011;51:77–83.

    Article  PubMed  Google Scholar 

  4. Scher AI, Stewart WF, Lieberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497–506.

    Article  PubMed  CAS  Google Scholar 

  5. Dodick DW. Chronic daily headache. N Engl J Med. 2006;354:158–65.

    Article  PubMed  CAS  Google Scholar 

  6. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9–160.

    Google Scholar 

  7. •• Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, for the Headache Classification Committee, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742–6. This reference highlights recent revised criteria for the diagnosis of chronic migraine.

    Article  PubMed  CAS  Google Scholar 

  8. •• Bigal ME, Rapoport A, Sheftell F, Tepper S, Lipton R. The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia. 2007;27:230–4. This reference highlights the reliability of revised criteria for the diagnosis of chronic migraine.

    Article  PubMed  CAS  Google Scholar 

  9. Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, et al. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache. 2008;48:1087–95.

    Article  PubMed  Google Scholar 

  10. Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13:177–89.

    Article  PubMed  CAS  Google Scholar 

  11. Gupta S, McCarson KE, Welch KM, Berman NE. Mechanisms of pain modulation by sex hormones in migraine. Headache. 2011;51:905–22.

    Article  PubMed  Google Scholar 

  12. Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, et al. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009;73:1796–803.

    Article  PubMed  CAS  Google Scholar 

  13. Queiroz LP, Barea LM, Blank M. An epidemiological study of headache in Florianopolis, Brazil. Cephalalgia. 2006;26:122–6.

    Article  PubMed  CAS  Google Scholar 

  14. Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M. Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache. 2005;45:25–31.

    Article  PubMed  Google Scholar 

  15. Theeler BJ, Flynn FG, Erickson JC. Chronic daily headache in U.S. soldiers after concussion. Headache. 2012;52:732–8.

    Article  PubMed  Google Scholar 

  16. Packard RC. Chronic post-traumatic headache: associations with mild traumatic brain injury, concussion, and post-concussive disorder. Curr Pain Headache Rep. 2008;12:67–73.

    Article  PubMed  Google Scholar 

  17. Sacco S, Ripa P, Carolei A. Migraine attributed to genetic disorder: proposal of a new category. Cephalalgia. 2011;31:760–2.

    Article  PubMed  Google Scholar 

  18. Serý O, Hrazdilová O, Matalová E, Sevcík P. Pain research update from a genetic point of view. Pain Pract. 2005;5:341–8.

    Article  PubMed  Google Scholar 

  19. Milde-Busch A, Blaschek A, Heinen F, Borggräfe I, Koerte I, Straube A, et al. Associations between stress and migraine and tension-type headache: results from a school-based study in adolescents from grammar schools in Germany. Cephalalgia. 2011;31:774–85.

    Article  PubMed  Google Scholar 

  20. Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50:1366–70.

    Article  PubMed  Google Scholar 

  21. Brighina F, Fierro B. Cortical hypoactivity or reduced efficiency of cortical inhibition in migraine? Cephalalgia. 2007;27:187–8.

    Article  PubMed  CAS  Google Scholar 

  22. Rains JC. Morning headache in habitual snorers. Cephalalgia. 2011;31:981–3.

    Article  PubMed  Google Scholar 

  23. Budhiraja R, Roth T, Hudgel DW, Budhiraja P, Drake CL. Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders. Sleep. 2011;34:859–67.

    PubMed  Google Scholar 

  24. Le Grand SM, Patumraj S, Phansuwan-Pujito P, Srikiatkhachorn A. Melatonin inhibits cortical spreading depression-evoked trigeminal nociception. Neuroreport. 2006;17:1709–13.

    Article  PubMed  Google Scholar 

  25. Gagnier JJ. The therapeutic potential of melatonin in migraines and other headache types. Altern Med Rev. 2001;6:383–9.

    PubMed  CAS  Google Scholar 

  26. Brun J, Claustrat B, Saddier P, Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia. 1995;15:136–9.

    Article  PubMed  CAS  Google Scholar 

  27. Evans RW, Williams MA, Rapoport AM, Peterlin BL. The association of obesity with episodic and chronic migraine. Headache. 2012;52:663–71.

    Article  PubMed  Google Scholar 

  28. Bernecker C, Ragginer C, Fauler G, Horejsi R, Möller R, Zelzer S, et al. Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol. 2011;18:1233–9.

    Article  PubMed  CAS  Google Scholar 

  29. Kaleagasi H, Özgür E, Özge C, Özge A. Bronchial hyper-reactivity in migraine without aura: is it a new clue for inflammation? Headache. 2011;51:426–31.

    Article  PubMed  Google Scholar 

  30. Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry. 2010;81:428–32.

    Article  PubMed  CAS  Google Scholar 

  31. Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–95.

    Article  PubMed  Google Scholar 

  32. Sacco S, Carolei A. Oxidative stress: a bridge between migraine and cardiovascular disease? Eur J Neurol. 2011;18:1201–2.

    Article  PubMed  CAS  Google Scholar 

  33. Sacco S, Carolei A. Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine. Neurology. 2009;72:2056–7.

    Article  PubMed  Google Scholar 

  34. • Sacco S, Cerone D, Carolei A. Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain. 2008;9:237–48. This reference helps the physician to recognize the comorbidities of migraine and their influence on chronification.

    Article  PubMed  Google Scholar 

  35. Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire. Headache. 2001;41:854–61.

    PubMed  CAS  Google Scholar 

  36. •• Andrasik F. Behavioral treatment of migraine: current status and future directions. Expert Rev Neurother. 2004;4:403–13. This review is of importance to identify the most recent studies about the characteristics and effectiveness of behavioral treatments.

    Article  PubMed  Google Scholar 

  37. Lipchik GL, Smitherman TA, Penzien DB, Holroyd KA. Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache. 2006;46:119–32.

    Article  Google Scholar 

  38. Rama S. Portal to higher awareness: the science of breath. In: Rama S, Ballentine R, Hymes A, editors. Science of breath. A practical guide. Honesdale: Himalayan Institute Press; 1998. p. 72–112.

    Google Scholar 

  39. Stoyva JM. Autogenic training and biofeedback combined: a reliable method for the induction of general relaxation. In: Basmajian JV, editor. Biofeedback: principle and practice for clinicians. 3rd ed. Baltimore: Williams & Wilkins; 1989. p. 169–85.

    Google Scholar 

  40. Evans RW, Penzien DB. Your headache is a cow. Headache. 2003;43:168–9.

    Article  PubMed  Google Scholar 

  41. Lutz A, Slagter HA, Dunne JD, Davidson RJ. Attention regulation and monitoring in meditation. Trends Cogn Sci. 2008;12:163–9.

    Article  PubMed  Google Scholar 

  42. • Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, Di Massimo C, Carolei A. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia. 2007;27:1136–41. This paper is of importance as it suggests a possible mechanism leading to the beneficial effect of biofeedback in patients with chronic migraine.

    Article  PubMed  CAS  Google Scholar 

  43. Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Olivieri L, Carolei A. Preventive nonpharmacological treatment and nitric oxide in chronic migraine. J Headache Pain. 2005;6:341–2.

    Article  PubMed  CAS  Google Scholar 

  44. Friar LR, Beatty J. Migraine: management by trained control of vasoconstriction. J Consult Clin Psychol. 1976;44:46–53.

    Article  PubMed  CAS  Google Scholar 

  45. Kropp P, Siniatchkin M, Gerber WD. On the pathophysiology of migraine links for “empirically based treatment” with neurofeedback. Appl Psychophysiol Biofeedback. 2002;27:203–13.

    Article  PubMed  Google Scholar 

  46. Andrasik F, Gerber WD. Relaxation, biofeedback, and stress-coping therapies. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press; 1993. p. 833–41.

    Google Scholar 

  47. Buse DC, Andrasik F. Behavioral medicine for migraine. Neurol Clin. 2009;27:445–65.

    Article  PubMed  Google Scholar 

  48. Rains JC. Chronic headache and potentially modifiable risk factors: screening and behavioral management of sleep disorders. Headache. 2008;48:32–9.

    Article  PubMed  Google Scholar 

  49. Goslin RE, Gray RN, McCrory DC, et al. Behavioral and physical treatments for migraine headache. Rockville: Agency for Health Care Policy and Research; 1999.

    Google Scholar 

  50. Wallasch TM, Angeli A, Kropp P. Outcomes of a headache-specific cross-sectional multidisciplinary treatment program. Headache. 2012;52:1094–105.

    Article  PubMed  Google Scholar 

  51. D’Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Ann Behav Med. 2008;36:21–32.

    Article  PubMed  Google Scholar 

  52. Mullally WJ, Hall K, Goldstein R. Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician. 2009;12:1005–11.

    PubMed  Google Scholar 

  53. Eccleston C, Palermo TM, Williams AC, Lewandowski A, Morley S. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2009;2:CD003968.

    PubMed  Google Scholar 

  54. Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain. 1995;20:239–56.

    Article  Google Scholar 

  55. Holden EW, Deichmann MM, Levy JD. Empirically supported treatments in pediatric psychology: recurrent pediatric headache. J Pediatr Psychol. 1999;24:91–109.

    Article  PubMed  CAS  Google Scholar 

  56. Hermann C, Blanchard EB. Biofeedback in the treatment of headache and other childhood pain. Appl Psychophysiol Biofeedback. 2002;27:143–62.

    Article  PubMed  Google Scholar 

  57. Nicholson RA, Buse DC, Andrasik F, Lipton RB. Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use. Curr Treat Options Neurol. 2011;13:28–40.

    Article  PubMed  Google Scholar 

  58. Martin PR. Managing headache triggers: think ‘coping’ not ‘avoidance’. Cephalalgia. 2010;30:634–7.

    PubMed  CAS  Google Scholar 

  59. Martin PR. How do trigger factors acquire the capacity to precipitate headaches? Behav Res Ther. 2001;39:545–54.

    Article  PubMed  CAS  Google Scholar 

  60. Martin PR, Reece J, Forsyth M. Noise as a trigger for headaches: relationship between exposure and sensitivity. Headache. 2006;46:962–72.

    Article  PubMed  Google Scholar 

  61. Martin PR, Lae L, Reece J. Stress as a trigger for headaches: relationship between exposure and sensitivity. Anxiety Stress Coping. 2007;20:393–407.

    Article  PubMed  Google Scholar 

  62. Attanasio V, Andrasik F, Blanchard EB. Cognitive therapy and relaxation training in muscle contraction headache: efficacy and cost-effectiveness. Headache. 1987;27:254–60.

    Article  PubMed  CAS  Google Scholar 

  63. Friedman R, Sedler M, Myers P, Benson H. Behavioral medicine, complementary medicine and integrated care. Economic implications. Prim Care. 1997;24:949–62.

    Article  PubMed  CAS  Google Scholar 

  64. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. US Headache Consortium. 2000. Available at: http://www.aan.com. Accessed July 17, 2012.

  65. Stanos S. Focused review of interdisciplinary pain rehabilitation programs for chronic pain management. Curr Pain Headache Rep. 2012;16:147–52.

    Article  PubMed  Google Scholar 

  66. Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2011;15:64–9.

    Article  PubMed  Google Scholar 

  67. Flor H, Diers M. Limitations of pharmacotherapy: behavioral approaches to chronic pain. Handb Exp Pharmacol. 2007;177:415–27.

    Google Scholar 

  68. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs structured detoxification programs for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26:1097–105.

    Article  PubMed  CAS  Google Scholar 

  69. Fuh JL, Wang SJ. Dependent behavior in patients with medication-overuse headache. Curr Pain Headache Rep. 2012;16:73–9.

    Article  PubMed  Google Scholar 

  70. Lake 3rd AE. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006;46:s88–97.

    Article  PubMed  Google Scholar 

  71. Nicholson RA. Chronic headache: the role of the psychologist. Curr Pain Headache Rep. 2010;14:47–54.

    Article  PubMed  Google Scholar 

  72. Diener HC. Detoxification for medication overuse headache is not necessary. Cephalalgia. 2012;32:423–7.

    Article  PubMed  Google Scholar 

  73. Grazzi L, Usai S, Prunesti A, Bussone G, Andrasik F. Behavioral plus pharmacological treatment vs pharmacological treatment only for chronic migraine with medication overuse after day-hospital withdrawal. Neurol Sci. 2009;30:S117–9.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Francesca Pistoia.

Additional information

This article is part of the Topical Collection on Chronic Daily Headache

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pistoia, F., Sacco, S. & Carolei, A. Behavioral Therapy for Chronic Migraine. Curr Pain Headache Rep 17, 304 (2013). https://doi.org/10.1007/s11916-012-0304-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-012-0304-9

Keywords

Navigation